EVALUATION OF THE PHARMACY SUPPORT SYSTEM IN THE DETECTION OF DRUG-RELATED PROBLEMS

Authors

  • Tri Murti Andayani Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
  • Fita Rahmawati Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
  • Rifky Rochman Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10s2.19497

Keywords:

Pharmacy support systems, Drug-related problems, Outpatients

Abstract

Objective: The efficiency and speed of a system in identifying DRPs can support and optimize the performance of pharmacists. The objective of this research was to determine the time of analysis and the number of DRPs incidences identified by pharmacists with and without Pharmacy Support Systems (PSS).

Methods: The present research was observational with cross-sectional design. The data collection was done prospectively in outpatients at hospital during January 2016. Observations were conducted to the difference between the analysis and the number of DRPs incidence identified by the pharmacists with and without the assistance of PSS. The research population was outpatient at a number of hospitals in Yogyakarta. The tools used in this research were PSS which were a clinical information system that can identify potential DRPs and included three main parts, namely the patients' profile, drug information, and analysis of DRPs. The identification result of DRPs was consisted of six DRPs categories, i.e. without treatment indication, treatment without indication, ineffective drug, too low dose, too high dose, and undesirable drug reactions.

Results: Pharmacists without PSS require faster time to analyze the prescription of outpatients. The time majority spent by pharmacists with PSS in reviewing the patients' prescription lies in the length of time the patients enter the therapy-related data obtained manually by patients until the warning being displayed, and making clinical decision related to the DRPs. The statistical test result using Goodness of fit test and Fisher between categories of DRPs incidences detected by pharmacists with and without the assistance of PPS indicates significant differences (P <0.05). Pharmacists with PSS can detect DRPs that are not detected by the pharmacist without PSS. DRPs mostly identified by pharmacists with the assistance of PSS are drug interactions and improper doses. Improper doses primarily identified in geriatric and pediatric patients' prescription.

Conclusion: Pharmacists with PSS software can detect DRPs that are not detected by pharmacists only. But pharmacists using the software PSS requires a longer time in the identification of DRPs compared to pharmacists without using PSS.

 

Downloads

Download data is not yet available.

References

Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997, 54: 554-8.

Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch P. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol, 60: 651–8.

Roten I, Marty S, Beney J. Electronic Screening of Medical Records to Detect Inpatients at Risk of Drug-Related Problems. Pharm World Sci 2010; 32: 103–7.

Tora H, Bo H, Bodil L, Göran P, Birgit E. Potential Drug Related Problems Detected by Electronic Expert Support System in Patients with Multi-Dose Drug Dispensing. Int J Clin Pharm 2014; 36: 943–52.

Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, et al. Patient risk factors for developing a drug-related problem in a cardiology ward. Ther Clin Risk Manag 2014, 11: 9–15.

Zaal RJ, Jansen MMPM, Duisenberg-van Essenberg M, Tijssen CC, Roukema JA, van den Bemt PMLA. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts. Int J Clin Pharm 2013; 35: 753762

Bossuyt, P.M.M., Reitsma, J.B., Linnet, K., dan Moons, K.G.M., 2012. Beyond Diagnostic Accuracy: The Clinical Utility of Diagnostic Tests. Clin Chem, 58: 1636–43.

Van der Sijs H, Bouamar R, van Gelder T, Aarts J, Berg M, Vulto A. Functionality test for drug safety alerting in computerized physician order entry systems. Int. J. Med. Inf 2010; 79: 243–51.

Coleman E, Aarts J, Kulikowski C. The Dangerous decade. J Am Med Inform Assoc ; 2012.p.2-5

Weingart SN, Simchowitz B, Padolsky H, Isaac T, Seger AC, Massagli M, et al. An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care. Arch Intern Med 2009, 169: 1465–73.

Hatfield MD, Cox R, Mhatre SK, Flowers WP, and Sansgiry SS. Impact of Computerized Provider Order Entry on Pharmacist Productivity. Hosp Pharm 2014; 49: 458–65.

Cipolle RJ, Strand LM, dan Morley PC. 1998. Pharmaceutical Care Practice; McGraw-Hill, Health Professions Division, New York; 1998.

Bates DW, Kuperman GJ, Wang S, Gandhi T, Kittler A, Volk L, et al. Ten Commandments for Effective Clinical Decision Support : Making the Practice of Evidence-Based Medicine a Reality. J Am Med Inform Assoc , 10:523-30

Fok M, Lo A. Quantifying the Impact of Prescription-Related Problems on Pharmacy Workload. Can J Hosp Pharm 2002;55:313-9

Tatro. Drug Interaction Fact 2012.

Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, Noskin GA. The Epidemiology of Prescribing Errors: The Potential Impact of Computerized Prescriber Order Entry. Arch Intern Med 2004; 164:785-92

Eppenga WL, Derijks HJ, Conemans JMH, Hermens WAJJ, Wensing M, De Smet PAGM. Comparison of a basic and an advanced pharmacotherapy-related clinical decision support system in a hospital care setting in the Netherlands. J Am Med Inform Assoc 2012;19:66-71

Scheepers-Hoeks AMJW. 'Alerts Methods as Success Factors: Influencing Effectiveness of a Clinical Decision Support System in Clinical Practice'. [thesis]. Netherlands: University of Technology Eindhoven; 2014

Published

01-05-2017

How to Cite

Andayani, T. M., F. Rahmawati, and R. Rochman. “EVALUATION OF THE PHARMACY SUPPORT SYSTEM IN THE DETECTION OF DRUG-RELATED PROBLEMS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 14, May 2017, pp. 90-93, doi:10.22159/ajpcr.2017.v10s2.19497.

Issue

Section

Original Article(s)